Skip to main content

Nasdaq IPOs

French biotech Biophytis prices US IPO at $16.75, within the range

5 years 7 months ago
Biophytis, a French Phase 2 biotech developing therapies for COVID-related complications and age-related diseases, raised $20 million by offering 1.2 million ADSs at $16.75, within the range of $15 to $18. The company is currently listed on the Euronext Growth Paris (AL
Renaissance Capital

SPAC Lazard Growth Acquisition I prices $500 million IPO

5 years 7 months ago
Lazard Growth Acquisition I, a blank check company formed by Lazard targeting growth-oriented subsectors, raised $500 million by offering 50 million units at $10. Each unit consists of one share of common stock and one-fifth of a warrant, exercisable at $11.50. The company
Renaissance Capital
Checked
19 minutes 22 seconds ago
This feed is responsible for generating the rss feed related to the topic IPOs
Subscribe to Nasdaq IPOs feed